Is Bortezomib given as an intravenous push or subcutaneous injection?

Bortezomib (Bortezomib) can be given to patients in two different ways, and the specific method of use is usually determined by the doctor based on the patient's specific situation and treatment plan. The two methods are intravenous injection and subcutaneous injection.

1.Intravenous bolus: Bortezomib can be given to patients as an intravenous bolus, usually by a medical professional under the supervision of a hospital or medical clinic. This approach is often used for initial treatment or in certain clinical situations because it ensures that the drug is delivered quickly into the patient's circulatory system and therefore has a faster onset of action. Intravenous injection requires professionally trained medical personnel to ensure the correct injection of the drug and monitor the patient's response.

2.Subcutaneous injection: Another way to give bortezomib is by subcutaneous injection, usually by the patient themselves or under the guidance of a doctor. This modality is often used for maintenance treatment or during treatment so that patients can receive injections at home. Patients often receive training to ensure they can self-inject correctly. Subcutaneous injections are relatively convenient and reduce frequent visits to the hospital or clinic.

Which method is used depends on the doctor's recommendations, the patient's treatment plan, and the patient's personal preferences. In any case, patients need to closely follow their doctor's recommendations, ensure that medications are administered correctly, and undergo regular medical monitoring to evaluate the efficacy and adverse effects of treatment. Whether administered as an intravenous injection or subcutaneous injection, bortezomib is an important anti-cancer drug that plays a key role in the treatment of cancers such as multiple myeloma.

Bortezomib is already on the market in China and has been included in medical insurance. Patients can purchase it domestically at a price of around 3,000 to 4,000 yuan. Please consult the local hospital pharmacy for specific prices and reimbursement policies. The cheaper ones abroad are mainly Indian generic drugs, which cost around 1,000 yuan and have basically the same ingredients as the domestic bortezomib drug.